Longevity Conference Attendees Hospitalized After Using Peptides?
Matt attended the RadFest conference in Las Vegas, which has a reputation for being on the more fringe side of the longevity and anti-aging field. He had previously only attended the conference remotely during COVID, so this was his first in-person experience. He noted that the main stage scientific content was quite good this year, but there was also a lot of questionable and unproven therapies being promoted in the vendor hall and side events.
The episode was prompted by a ProPublica article reporting that two women were hospitalized in critical condition after receiving peptide injections at a booth run by a California doctor who was not licensed to practice in Nevada. Matt explains that peptides are a broad class of bioactive molecules, some of which have shown promise but many of which are still poorly understood in terms of safety and efficacy, especially when used in unregulated cocktails.
Matt discusses the broader challenges at conferences like RadFest, where legitimate science is presented alongside more speculative and unproven therapies. He notes that most attendees seem to be well-intentioned, but there is a lack of critical thinking and a tendency towards libertarian views on health freedom that can lead to unsafe practices. He emphasizes the need for greater consequences for those making deceptive medical claims.
The article describes the investigation by Nevada authorities into the hospitalization incident, including the lack of proper licensing and oversight for the therapies being provided at the conference. Matt is cautiously optimistic that this incident will lead to more care and scientific rigor being applied at future RadFest events, though he acknowledges the organizers' good intentions.
Matt then shares his own disturbing experience at RadFest, where he was invited to a hotel room to witness someone providing unregulated exosome injections, which he describes as being on the "deep end" of the fringe therapies promoted at the conference. He struggles to understand the irrational risk tolerance of some attendees, even those with scientific backgrounds, and sees it as an illustration of the wider challenges in this space.